%2002-Mar-2007_files/image002.jpg)
|
Report Date : |
02.03.2007 |
IDENTIFICATION
DETAILS
|
Name : |
TENTH OF RAMADAN PHARMACEUTICALS INDUSTRIES
DIOGNOSTIC REAGENTS (RAMEDA) |
|
|
|
|
Registered Office : |
2nd
Industrial Zone, Plot No.5, St. No. 20, Giza, 6th of October City |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
1988 |
|
|
|
|
Com. Reg. No.: |
8008 |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Engaged
in the manufacture and export of pharmaceuticals and diagnostic chemicals. |
RATING &
COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
US$ 500,000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
SUMMARY
Company Name :
TENTH
OF RAMADAN PHARMACEUTICALS INDUSTRIES
DIOGNOSTIC REAGENTS (RAMEDA)
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 1988
Commercial Registration Number : 8008
Issued Capital : £E 120,000,000
Paid up Capital : £E 120,000,000
Total Workforce : 450
Line of Business : Manufacture and export of pharmaceuticals and diagnostic chemicals.
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
COMPANY NAME
TENTH OF RAMADAN PHARMACEUTICALS INDUSTRIES DIOGNOSTIC
REAGENTS (RAMEDA)
ADDRESS
Location : 2nd
Industrial Zone, Plot No.5, St. No. 20
Area : Giza
Town : 6th
of October City
Country : Egypt
Telephone : (20-2) 8331848
/ 8331849 / 8331766 / 8331773
Facsimile : (20-2) 8335606
Premises
Subject operates
from a large suite of offices and a factory that are owned and located in the
Industrial Area of the 6th of October City
Branch Office (s)
Location Description
·
40
A Mohamed Mazhar Street Rented
office premises
Zamalek
Cairo
Tel: (20-2)
7382190 / 7382191
Fax: (20-2) 7355534
KEY PRINCIPALS
·
Zeyad
Hassan El Rawashda Chairman
·
Moustafa
Wafaie Abd El Rahman Managing
Director
·
Hassan
Mahmoud Director
·
Gomaa
Abel Director
·
Adel
Metawea Director
·
Shafik
Balbaa Director
·
Farouk
Ghourab Director
·
Adeeb
Khalil Finance
Manager
·
Tarek
Gharib Accounts
Manager
·
Dr.
Mohamed Moustafa El Barky Factory
Manager
·
Akram
El Hefenawy Administration
Manager
LEGAL FORM &
OWNERS
Date of Establishment : 1988
Legal Form :
Societe Anonyme Egyptienne –
SAE (Egyptian Joint Stock Company)
Commercial Reg. No. : 8008
Issued Capital : £E 120,000,000
Paid up Capital : £E 120,000,000
Name of Shareholder
(s)
·
Islamia
for Gulf Investment (Aliahams)
Switzerland
·
Islamia
for Gulf Investment (El Sharka)
United Arab Emirates
·
Comprehensive
Bahrain Bank
Bahrain
·
Egyptian
businessmen & private investors
Note to the Legal Form
The Egyptian Company Law provides that the capital of a Societe
Anonyme Egyptienne - SAE – should not be less than £E 500,000 if shares are
offered to the public and £E 250,000 if not. If shares are offered to the
public they are freely transferable, if not, transfer may be restricted.
Liability of shareholders is limited.
LINE OF BUSINESS
Operations : Engaged in the
manufacture and export of pharmaceuticals and diagnostic chemicals.
Import Countries
: United States of America,
Japan and India.
Export Countries
: Yemen
and Somalia
Subject has a
workforce of approximately 450 employees.
FINANCIAL HIGHLIGHTS
Companies registered
in Egypt are not legally required to make their accounts public and no
financial information was released by the company or submitted by outside
sources.
BANKERS
·
National Bank
of Egypt
24, Sherif Street
Cairo
Tel : (20-2) 3924175
Fax : (20-2) 3924143
·
Commercial
International Bank (CIB)
Nile Tower Building
21-23 Giza Street
PO Box : 2430
Cairo
Tel : (20-2) 5703043
Fax : (20-2) 5703172 / 5072691
PAYMENT HISTORY
No complaints
regarding subject’s payments have been reported.
GENERAL COMMENTS
Opinion on the
credit figure of US$ 150,000
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk and the above credit figure is
within subject’s financial means.
Maximum suggested
credit figure: US$ 500,000
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions